AI MARKET SCANNING

Cytokinetics, Incorporated

AVG HISTORICAL GAP +0.18%
MAX GAP RECORD +13.08%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $CYTK
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 06, 2026 Earnings Release 2026-08-06 (AFTER CLOSE)
-0.17%
May 05, 2026 Earnings Release 2026-05-05 (BEFORE OPEN)
+13.08%
Feb 24, 2026 Earnings Release 2026-02-24 (AFTER CLOSE)
-2.82%
Nov 05, 2025 Earnings Release 2025-11-05 (AFTER CLOSE)
-0.57%
Aug 07, 2025 Earnings Release 2025-08-07 (AFTER CLOSE)
+1.70%
May 06, 2025 Earnings Release 2025-05-06 (AFTER CLOSE)
+4.03%
Feb 27, 2025 Earnings Release 2025-02-27 (AFTER CLOSE)
-6.51%
Nov 06, 2024 Earnings Release 2024-11-06 (AFTER CLOSE)
-0.92%

VOLATILITY & GAP BIAS

AVG GAP MOVE 3.2%
Bullish Gaps (5)
Bearish Gaps (5)
Neutral / Flat (5)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $CYTK

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten,…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗